Brief: Genmab To Buy Merus For USD 8.0 Billion
29/09/2025 06:28
Sept 29 (Reuters) - Genmab A/S GMAB.CO: GENMAB TO ACQUIRE MERUS, EXPANDING LATE-STAGE PIPELINE AND ACCELERATING INTO A WHOLLY OWNED MODEL GENMAB A/S - TO BUY MERUS FOR USD 8.0 BILLION GENMAB A/S - DEAL EXPECTED TO BE ACCRETIVE TO EBITDA BY 2029 GENMAB A/S - USD 97.00 PER SHARE REPRESENTS 41% PREMIUM OVER CLOSING PRICE Source text: ID:nGNXbNxYqj Further company coverage: GMAB.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Says Orbis Investment Management Holds 4.99% Of Genmab Voting Rights As Of June 12
Brief: Genmab Announces Epcoritamab Monotherapy And Epcoritamab-Based Combination Regimens Demonstrate High Response Rates In Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Brief: Genmab Presents Epcore Fl-1 Data Showing Consistent Efficacy, Safety For Epcoritamab Combination
Brief: Genmab Says Orbis Investment Management Limited Holds 5.08% Of Genmab A/S As Of May 8, 2026
Genmab falls after 'uneventful' Q1, profit miss